Literature DB >> 8772544

Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.

P Moghetti1, R Castello, C Negri, F Tosi, G G Spiazzi, E Brun, R Balducci, V Toscano, M Muggeo.   

Abstract

Recent data suggest that insulin is a modulator of ovarian and adrenal steroidogenesis and that, in the ovary of hyperandrogenic women, hyperinsulinemia might cause dysregulation of cytochrome P450c17 alpha activity. To further assess in vivo the effects of insulin on adrenal steroidogenesis, ACTH stimulation was carried out in 21 hyperandrogenic women during a 3-h hyperinsulinemic (80 mU/m2-min) euglycemic clamp. In all of these women the procedure was repeated during saline infusion as n control. In nonamenorrheic patients, the tests were performed in the early follicular phase of two different menstrual cycles. Serum cortisol, progesterone, 17-hydroxypregnenolone (17-OHJPREG). 17-hydroxyprogesterone (17-OHP), dehydroepiandrosterone (DHEA), and androstenedione (A) were measured after 2 h of insulin or saline infusion (zero time) and, subsequently, 30 and 60 min after an iv bolus of 0.25 mg ACTH-(1-24). At zero time, no difference was found in the serum steroid concentrations between the two protocols. ACTH-stimulated serum 17-OHPREG and, to a lesser extent, 17-OHP were significantly higher during insulin than during saline infusion (peaks, 60.6 +/- 9.0 vs. 40.7 +/- 7.9 and 7.7 +/- 7.7 vs. 6.6 +/- 0.6 nmol/L; P < 0.005 and P < 0.01, respectively). Serum DHEA was also slightly higher during hyperinsulinemia, although only after 30 min (54.5 +/- 3.0 vs. 48.2 +/- 4.2 nmol/L; P < 0.05). No statistically significant difference in the cortisol, progesterone, or androstenedione response to ACTH was found between the two protocols. ACTH-stimulated 17-OHPREG/DHEA and 17-OHP/A molar ratios, indexes of apparent 17,20-lyase activity, were significantly higher during the clamp studies than during saline infusion (by ANOVA, F = 12.8; P < 0.001 and F = 6.7; P < 0.005, respectively), suggesting an impaired enzyme activity. These in vivo data support the hypothesis that insulin potentiates ACTH-stimulated steroidogenesis. This effect of insulin seems to be associated with a relative impairment of 17,20-lyase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772544     DOI: 10.1210/jcem.81.3.8772544

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

Review 1.  Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 2.  New routes in the polycystic ovary syndrome labyrinth: a way out?

Authors:  P Moghetti; R Castello
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 3.  Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 4.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 5.  Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2011-10-09       Impact factor: 3.201

Review 6.  Insulin resistance and PCOS: chicken or egg?

Authors:  P Moghetti; F Tosi
Journal:  J Endocrinol Invest       Date:  2020-07-09       Impact factor: 4.256

Review 7.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

8.  Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion.

Authors:  C M Burt Solorzano; C R McCartney; S K Blank; K L Knudsen; J C Marshall
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 10.  Nonhuman primates as models for human adrenal androgen production: function and dysfunction.

Authors:  D H Abbott; I M Bird
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.